Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orteronel in nonmetastatic CRPC
NCT01046916Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- May 2010
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of orteronel in prostate cancer (PCa), sponsored by Millennium Pharmaceuticals. Started May 2010; status: completed.
02
Drugs
orteronel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT01046916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01046916.